Opulus™ Lymphoma Precision
Roche Molecular Systems, Inc.
Authorized purpose: Opulus Lymphoma Precision segments and visualizes lesions and measures total metabolic tumor volume in whole-body FDG-PET/CT for patients already diagnosed with FDG-avid lymphoma; trained physicians can accept/reject annotated output, but radiologist review makes the final interpretation and the device is not a screening/diagnostic substitute.
- Modality
- PET/SPECT/Nuclear Medicine
- Anatomy
- Whole-body FDG-PET/CT
- Decision
- 2025-05-30